Keywords: celgene, buys, out, entremed, thalidomide, acquired, exclusive

Celgene Buys Out EntreMed From Thalidomide

Article | 16 December 1998

Celgene has acquired exclusive worldwide rights to EntreMed's patentsand technology relating to thalidomide, as well as US orphan drug designations ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Thalidomide

Thalomid

Go to drug listing